SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Five pages from Marvel’s new Star Wars series shows Jedi badassery at its height
In these five unlettered pages from Star Wars: Jedi Knights #1, which Polygon can reveal courtesy of Marvel Comics, being ...
Did Hilma af Klint draw inspiration from 19th century physics?
Af Klint was formally trained at the Royal Academy of Fine Arts and initially focused on drawing, portraits, botanical ...
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Long Island Press1d
Guggenheim Elementary guest speaker shares experiences in Africa
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Salesforce Stock’s AI Rally Is Over, Analyst Says. Why Now Could Be the Time to Sell.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.
Palo Alto Networks downgraded to Sell from Neutral at Guggenheim
Guggenheim downgraded Palo Alto Networks (PANW) to Sell from Neutral with a $130 price target Stay Ahead of the Market:Discover outperforming ...
Morningstar2d
Guggenheim Macro Opportunities A
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...